glp 1 for inflammation and pain Low Dose GLP-1 Inflammation: Evidence Safety Advances in GLP-1 receptor agonists

Dont let anyone conflate the two.) So your answer is the cleanest probably yes in this whole article, and the reason is encouraging rather than mystical: the drug is helping you shed the exact tissue that was raising your risk in the first place

10.3390/ijms221910835 20 BhadadaS

Medical professionals considering clinical use should source BPC-157 from reputable suppliers with third-party analytical verification and appropriate quality control documentation to minimize risks associated with contaminated or mislabeled products

In practice, the wound measurement, anatomical site classification, closure documentation, and modifier logic generate more billing friction than the procedures simplicity would suggest